Comparison of the effects of adrafinil, propentofylline, and nicergoline on behavior in aged dogs

American Journal of Veterinary Research

Volumn 61, Issue 11, 2000, Pages 1410-1414

  Siwak, Christina T ^a   Gruet, Philippe ^b   Woehrlé, Frédérique ^b   Muggenburg, Bruce A ^c   Murphey, Heather L ^c   Milgram, Norton W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Vetoquinol Specialites P   (France)

^c AIR FORCE RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRAFINIL; NICERGOLINE; PROPENTOFYLLINE;

AGED; ALERTNESS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CAGE; DOG; DRUG EFFECT; DRUG EFFICACY; EXPLORATORY BEHAVIOR; FEMALE; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; QUALITY OF LIFE; SNIFFING;

ANIMALIA; CANIS FAMILIARIS;

EID: 0033768490     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.1410     Document Type: Article

References (27)

1. Israel L, Fondarai J, Lubin S, et al. L'Adrafinil (Olmifon) et patients âgés ambulatoires. Efficacité, versus placebo, de l'Adrafinil sur l'éveil dans les activités de la vie quotidienne. Psychol Médicale 1989;21:1235-1255.
2. Kohler F, Lubin S. Étude en médecine générale de l'intérêt thérapeutique d'Olmifon chez des malades présentant des symptomes précoces de vieillissement cérébral handicapant leur activité quotidienne. Étude ouverte pragmatique chez 304 patients. La Vie Médicale 1990;2:335-344.
3. Rambert FA, Pessonnier J, De Sereville J-E, et al. Profil psychopharmacologique riginil de l'Adrafinil chez le Souris. J Pharmacol (Paris) 1986;17:37-52.
4. Milhaud CL, Klein MJ. Effects de l'Adrafinil sur l'activité nocturne du macaque rhésus (Macaca mulatta). J Pharmacol (Paris) 1985;16:372-380.
5. Delini-Stula A, Hunn C. Effects of single and repeated treatment with antidepressants on the apomorphine-induced yawning in the rat: the implication of α-1 adrenergic mechanisms in the D-2 receptor function. Psychopharmacology (Berl) 1990;101:62-66.
6. Siwak CT, Gruet P, Woehrlé F, et al. Behavioral activating effects of adrafinil in aged canines. Pharmacol Biochem Behav 2000;in press.
7. Simon P, Hemet C, Costentin J. Analysis of stimulant locomotor effects of modafinil in various strains of mice and rats. Fundam Clin Pharmacol 1996;10:431-435.
8. Touret M, Sallanon-Moulin M, Jouvet M. Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat. Neurosci Lett 1995;189:43-46.
9. Hermant J-F, Rambert FA, Duteil J. Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration. Psychopharmacology (Berl) 1991;103:28-32.
10. Milgram NW, Siwak C, Gruet P, et al. Oral administration of adrafinil improves discrimination learning in aged beagle dogs. Pharmacol Biochem Behav 2000;in press.
11. Duteil J, Rambert FA, Pessonnier J, et al. A possible alpha-adrenergic mechanism of drug (CRL 40028)-induced hyperactivity. Eur J Pharmacol 1979;59:121-123.
12. 1-and β-adrenoceptors in the rat cerebral cortex. Physiol Behav 1986;38:53-55.
13. Tanganelli S, Fuxe K, Ferraro L, et al. Inhibitory effects of the psychoactive drug modafinil on γ-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Naunyn Schmiedebergs Arch Pharmacol 1992;345:461-465.
14. Ferraro L, Tanganelli S, O'Connor WT, et al. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol 1996;306:33-39.
15. Touret M, Sallanon-Moulin M, Fages C, et al. Effect of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain. Mol Brain Res 1994;26:123-128.
16. Fredholm BB, Lindström F. The xanthine derivative 1-(5-oxohexyl)-3-methyl-7-propyl xanthine (HWA) enhances the actions of adenosine. Acta Pharmacol Toxicol 1986;58:187-192.
17. Banati RB, Schubert P, Rothe G, et al. Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline. J Cereb Blood Flow Metab 1994;14:145-149.
18. Parkinson FE, Johansson B, Lindström K, et al. Adenosine A1 and A2a receptors and nitrobenzylthioinsine-sensitive transporters in gerbil brain: no changes following long-term treatment with the adenosine transport inhibitor propentofylline. Neuropharmacology 1996;35:79-89.
19. Fuji K, Hiramatsu M, Kameyama T, et al. Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats. Eur J Pharmacol 1993;236:411-417.
20. Haraguchi H, Kuribara H. Behavioral effects of adenosine agonists: evaluation by punishment, discrete shuttle avoidance and activity tests in mice. Japan J Pharmacol 1991;55:303-310.
21. Alzheimer research forum. Available at: http://www.alzforum.org. Accessed Jun 19, 2000.
22. Moretti A, Carfagna N, Caccia C, et al. Effect of ergolines on neurotransmitter systems in the rat brain. Arch Int Pharmacodyn Ther 1988;294:33-45.
23. 2+ channels in rat isolated hippocampal CA1 pyramidal neurones. Br J Pharmacol 1990;100:705-710.
24. Voronina TA, Nerobkova LN, Garibova TL, et al. Effect of nicergoline on learning and memory. Methods Find Exp Clin Pharmacol 1988;10:431-435.
25. McArthur RA, Carfagna N, Banfk L, et al. Effects of nicergoline on age-related decrements in radial maze performance and acetylcholine levels. Brain Res Bull 1997;43:305-311.
26. Head E, Milgram NW. Changes in spontaneous behaviour in the dog following oral administration of L-deprenyl. Pharmacol Biochem Behav 1992;43:749-757.
27. Raskin LA. The influence of environmental variables on amphetamine-induced activity in the preweanling rat. Pharmacol Biochem Behav 1983;19:187-191.